Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Clinical Trial Paradigms in the Era of Novel Therapies

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Clinical Trial Paradigms in the Era of Novel Therapies
New paradigms for early-phase clinical trials
James H. Doroshow
National Cancer Institute, Bethesda, MD, United States
from 2011 Molecular Targets and Cancer Therapeutics conference on November 12, 2011 3:30 PM-5:30 PM
Clinical Trial Paradigms in the Era of Novel Therapies
Phasing out phase III trials: How much evidence do we need if the target is clearly hit?
Jaap Verweij
Erasmus University Medical Center - Daniel den Hoed Cancer Center, Rotterdam, Netherlands
from 2011 Molecular Targets and Cancer Therapeutics conference on November 12, 2011 3:30 PM-5:30 PM
Clinical Trial Paradigms in the Era of Novel Therapies
Development of clinical trials incorporating genomic signatures: Lessons learned
Lisa M McShane
National Cancer Institute, Bethesda, MD, United States
from 2011 Molecular Targets and Cancer Therapeutics conference on November 12, 2011 3:30 PM-5:30 PM
Clinical Trial Paradigms in the Era of Novel Therapies
Clinical trial designs for targeted therapies
John J. Crowley
Cancer Research and Biostatistics, Seattle, WA, United States
from 2011 Molecular Targets and Cancer Therapeutics conference on November 12, 2011 3:30 PM-5:30 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4